Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Abstract

Liposomal amphotericin B is as effective as conventional amphotericin B for empirical antifungal therapy in patients with fever and neutropenia, and it is associated with fewer breakthrough fungal infections, less infusion-related toxicity, and less nephrotoxicity.